financetom
Business
financetom
/
Business
/
Evolus Gets US FDA Approval for Injectable Hyaluronic Acid Gels
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Evolus Gets US FDA Approval for Injectable Hyaluronic Acid Gels
Feb 13, 2025 11:30 AM

02:10 PM EST, 02/13/2025 (MT Newswires) -- Evolus ( EOLS ) said Thursday it received approval from the US Food and Drug Administration for Evolysse Form and Evolysse Smooth injectable hyaluronic acid gels.

The beauty company said it intends to launch the products in the US market in Q2. It plans to launch Evolysse Sculpt in 2026 and Evolysse Lips in 2027.

Shares of the company were up over 6% in recent trading.

Price: 15.22, Change: +0.96, Percent Change: +6.73

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved